Overview

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying how well aspirin works in preventing colorectal cancer in patients at increased risk of colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of aspirin may prevent colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Aspirin